Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Applied DNA Sciences, Inc. APDN
$1.07
-$0.01 (-0.70%)
На 18:01, 12 мая 2023
+647.66%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
13941180.00000000
-
week52high
7.35
-
week52low
0.62
-
Revenue
18168677
-
P/E TTM
-2
-
Beta
0.46608900
-
EPS
-0.60000000
-
Last Dividend
0.00000000
-
Next Earnings Date
11 мая 2023 г. в 20:00
Описание компании
Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications used to fortify brand protection efforts and strengthen supply chain security, as well as mark, track, and convict criminals; SigNify IF portable DNA readers and SigNify consumable reagent test kits that provide real-time authentication of molecular tags in the field; and CertainT, which indicates the use of tagging, testing, and tracking platforms and solutions enabling manufacturers, brands, and trade organizations to convey proof of their product claims. It also manufactures and sells COVID-19 PCR-based molecular diagnostic test kit under the LineaTM COVID-19 Assay Kit trademark; and COVID-19 diagnostic test kit to prevent virus spread within a community, school, or workplace under the safeCircle trademark. In addition, the company provides preclinical contract research and manufacturing services for the nucleic acid-based therapeutic markets; and contract research services to RNA based drug and biologic customers for preclinical studies. Further, it develops an invasive circulating tumor cell capture and identification technology that uses a patented functional assay to capture live invasive circulating tumor cell and associated lymphocytes. The company operates in the United States, Europe, Asia, and internationally. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| HC Wainwright & Co. | Buy | Buy | 08 авг 2022 г. |
| HC Wainwright & Co. | Buy | Buy | 16 мая 2022 г. |
| HC Wainwright & Co. | Buy | Buy | 11 февр 2022 г. |
| HC Wainwright & Co. | Buy | Buy | 13 авг 2021 г. |
| HC Wainwright & Co. | Buy | Buy | 22 апр 2021 г. |
| HC Wainwright & Co. | Buy | Buy | 15 дек 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Schmalz Elizabeth M | A | 75099 | 75099 | 25 янв 2023 г. |
| Simon Sanford R | A | 38489 | 38489 | 25 янв 2023 г. |
| Simon Sanford R | A | 75099 | 75099 | 25 янв 2023 г. |
| Ceccoli Joseph D. | A | 41305 | 41305 | 25 янв 2023 г. |
| Ceccoli Joseph D. | A | 75099 | 75099 | 25 янв 2023 г. |
| SHAMASH YACOV A | A | 46938 | 46938 | 25 янв 2023 г. |
| SHAMASH YACOV A | A | 75099 | 75099 | 25 янв 2023 г. |
| Anchin Scott L | A | 37550 | 37550 | 25 янв 2023 г. |
| Anchin Scott L | A | 75099 | 75099 | 25 янв 2023 г. |
| CATELL ROBERT B | A | 39428 | 39428 | 25 янв 2023 г. |
Новостная лента
Applied DNA Sciences, Inc. (APDN) Q2 2023 Earnings Call Transcript
Seeking Alpha
11 мая 2023 г. в 22:54
Applied DNA Sciences, Inc. (NASDAQ:APDN ) Q2 2023 Results Earnings Conference Call May 12, 2023 4:30 PM ET Company Participants Sanjay Hurry - Head of Investor Relations Beth Jantzen - Chief Financial Officer James Hayward - Chairman, President and Chief Executive Officer Conference Call Participants Jason McCarthy - Maxim Group Yi Chen - H.C. Wainwright & Co., LLC Operator Hello and welcome to the Applied DNA Sciences Fiscal Second Quarter 2023 Financial Results.
Applied DNA to Report Second Quarter Fiscal 2023 Financial Results and Host Investor Conference Call and Webcast on Thursday, May 11, 2023
Business Wire
03 мая 2023 г. в 15:00
STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #LinearDNA--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in polymerase chain reaction (PCR)-based technologies, today announced that it will release financial results for the three months ended March 31, 2023 after the market close on Thursday, May 11, 2023. The Company will host a conference call for the investment community to discuss the results and answer questions at 4:30 p.m. ET. Date & Time: Thursday, May 11 @ 4:30 p.m.
What Makes Applied DNA Sciences (APDN) a New Buy Stock
Zacks Investment Research
15 февр 2023 г. в 13:33
Applied DNA Sciences (APDN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Applied DNA Sciences, Inc. (APDN) Q1 2023 Earnings Call Transcript
Seeking Alpha
09 февр 2023 г. в 20:59
Applied DNA Sciences, Inc. (NASDAQ:APDN ) Q1 2023 Earnings Conference Call February 9, 2023 4:30 PM ET Company Participants Sanjay Hurry - Investor Relations Beth Jantzen - Chief Financial Officer James Hayward - Chairman, President and Chief Executive Officer Clay Shorrock - Chief Legal Officer and Executive Director of Business Development Conference Call Participants Jason McCarthy - Maxim Group LLC Yi Chen - H.C. Wainwright & Co, LLC Operator Good afternoon, and welcome to the Applied DNA Sciences' First Quarter Fiscal 2023 Financial Results Conference Call.
Applied DNA to Report First Quarter Fiscal 2023 Financial Results and Host Investor Conference Call and Webcast on Thursday, February 9, 2023
Business Wire
02 февр 2023 г. в 10:00
STONY BROOK, N.Y.--( BUSINESS WIRE )--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in polymerase chain reaction ("PCR")-based technologies, today announced that it will release financial results for the three months ended December 31, 2022, after the market closes on Thursday, February 9, 2023. The Company will host a conference call for the investment community to discuss its results and answer questions at 4:30 p.m. ET.